VIRIDIAN THERAPEUTICS INC's ticker is VRDN and the CUSIP is 92790C104. A total of 27 filers reported holding VIRIDIAN THERAPEUTICS INC in Q2 2021. The put-call ratio across all filers is - and the average weighting 0.3%.
Quarter-by-quarter ownership
| Value | Shares | Weighting | ||||
|---|---|---|---|---|---|---|
| Q2 2023 | $4,799,680 | -16.4% | 201,752 | -59.3% | 5.81% | +11.1% |
| Q2 2022 | $5,739,000 | -37.4% | 496,012 | 0.0% | 5.23% | -23.1% |
| Q1 2022 | $9,171,000 | -23.3% | 496,012 | -18.0% | 6.80% | +62.7% |
| Q4 2021 | $11,956,000 | -19.7% | 604,774 | -33.2% | 4.18% | -4.5% |
| Q3 2021 | $14,887,000 | -5.3% | 904,978 | +5.2% | 4.38% | +12.0% |
| Q2 2021 | $15,728,000 | +38.3% | 859,910 | +26.3% | 3.91% | +79.1% |
| Q1 2021 | $11,376,000 | – | 680,768 | – | 2.18% | – |
Download | ||||||
Other shareholders
| Name | Shares | Value | Weighting ↓ |
|---|---|---|---|
| VR Adviser, LLC | 3,082,622 | $47,287,421 | 4.98% |
| COMMODORE CAPITAL LP | 2,200,000 | $33,748,000 | 3.94% |
| Paradigm Biocapital Advisors LP | 3,681,747 | $56,477,999 | 3.83% |
| Vivo Capital, LLC | 1,678,207 | $25,743,695 | 2.82% |
| Fairmount Funds Management LLC | 1,369,623 | $21,010,017 | 2.53% |
| Octagon Capital Advisors LP | 1,067,143 | $16,369,974 | 2.52% |
| ACUTA CAPITAL PARTNERS, LLC | 224,339 | $3,441,360 | 2.31% |
| Logos Global Management LP | 1,050,000 | $16,107,000 | 2.15% |
| Kopp Family Office, LLC | 214,290 | $3,287 | 2.08% |
| 5AM Venture Management, LLC | 410,000 | $6,289,400 | 1.81% |